Exelixis (EXEL) Inventory Average (2013 - 2026)
Exelixis (EXEL) recorded quarterly Inventory Average of $24.1 million in Q2 2026, down 1.62% quarter-over-quarter from $24.5 million in Q1 2026, and up 2.22% on a YoY basis from $23.6 million in Q2 2025.
Exelixis (EXEL) Inventory Average (2013 - 2026) Analysis & Trends
Exelixis' Inventory Average history runs 14 years deep, the most recent figure standing at $24.1 million for Q2 2026.
- In Q2 2026, Inventory Average rose 2.22% year-over-year to $24.1 million; the TTM figure through Apr 2026 stood at $24.1 million (up 2.22% YoY), while the FY2026 annual figure was $22.0 million, up 10.99% from the prior year.
- Inventory Average was $24.1 million for Q2 2026 at Exelixis, down from $24.5 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $31.6 million in Q1 2023 to a low of $19.2 million in Q1 2024.
- Historically, Inventory Average has averaged $25.4 million across 5 years, with a median of $24.5 million in 2026.
- The sharpest annual moves came in 2022 and 2024: Inventory Average rose 23.62% in 2022, then slumped 39.2% in 2024.
- A 5-year view of Inventory Average shows it stood at $30.0 million in 2022, then slipped by 29.51% to $21.2 million in 2023, then fell by 1.59% to $20.8 million in 2024, then climbed by 22.24% to $25.4 million in 2025, then slipped by 5.1% to $24.1 million in 2026.
- The last three Inventory Average figures came in at $24.1 million (Q2 2026), $24.5 million (Q1 2026), and $25.4 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Exelixis | 13.37 Bn | 12.59 Bn | 590.86 Mn | 24.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 24.15 Mn |
| Jan 2, 2026 | 24.54 Mn |
| Oct 3, 2025 | 25.44 Mn |
| Jul 4, 2025 | 24.17 Mn |
| Apr 4, 2025 | 23.62 Mn |
| Jan 3, 2025 | 21.70 Mn |
| Sep 27, 2024 | 20.81 Mn |
| Jun 28, 2024 | 20.86 Mn |
| Mar 29, 2024 | 19.21 Mn |
| Dec 29, 2023 | 21.15 Mn |
| Sep 29, 2023 | 26.81 Mn |
| Jun 30, 2023 | 29.27 Mn |
| Mar 31, 2023 | 31.60 Mn |
| Dec 30, 2022 | 30.01 Mn |
| Sep 30, 2022 | 29.87 Mn |
| Jul 1, 2022 | 30.74 Mn |
| Apr 1, 2022 | 27.98 Mn |
| Dec 31, 2021 | 27.87 Mn |
| Oct 1, 2021 | 26.61 Mn |
| Jul 2, 2021 | 24.87 Mn |